[Visudyne photodynamic therapy and feeder vessel occlusion: rationale of a synergistic association and clinical options].
D000792:Angiography / Q000379:methods; D002829:Choroid / Q000098:blood supply; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D004396:Coloring Agents; D005260:Female; D005500:Follow-Up Studies; D005584:Fovea Centralis / Q000098:blood supply; D006801:Humans; D007208:Indocyanine Green; D008028:Light Coagulation; D008268:Macular Degeneration / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D009887:Ophthalmoscopy; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D011166:Porphyrins / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D000077362:Verteporfin; D014792:Visual Acuity
D004396:Coloring Agents; D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin; D007208:Indocyanine Green
Photothérapie dynamique à la Visudyne et occlusion du vaisseau afférent: rationnel d'une association synergique et options cliniques illustrées.